Streetbeat News

Stock Prices

MYMD

MyMD Pharmaceuticals has rebranded to TNF Pharmaceuticals and will begin trading under the new symbol 'TNFA' on Nasdaq starting July 24, 2024. The rebranding aligns with the company's focus on TNF-alpha inhibitors for treating age-related diseases and autoimmune conditions.

Portfolio Pulse from Benzinga Newsdesk

July 22, 2024 | 1:02 pm

ITCI

Intra-Cellular Therapies (NASDAQ: ITCI) received mixed analyst recommendations over the last quarter, with a majority being bullish. The average 12-month price target increased to $99.18. The company showed strong revenue growth but faces challenges in profitability and financial performance.

Portfolio Pulse from Benzinga Insights

July 22, 2024 | 1:00 pm

SWN

Analysts have provided mixed ratings for Southwestern Energy (NYSE:SWN) over the past three months, with a recent average price target of $8.33. The company's financials show challenges, including a significant revenue decline and below-average profitability metrics.

Portfolio Pulse from Benzinga Insights

July 22, 2024 | 1:00 pm

RCM

8 analysts have shared their evaluations of R1 RCM (NASDAQ:RCM) over the past three months, showing a mix of bullish and bearish perspectives. The average 12-month price target is $17.38, with a high of $20.00 and a low of $15.00. Recent ratings include 'Buy', 'Hold', 'Overweight', and 'Outperform'. R1 RCM has shown a revenue growth rate of 10.69% but faces challenges with a net margin of -5.81% and an ROA of -0.65%.

Portfolio Pulse from Benzinga Insights

July 22, 2024 | 1:00 pm

XPEV

XPeng shares are trading higher following a report indicating the company and Volkswagen signed an agreement to develop EV infrastructure.

Portfolio Pulse from Benzinga Newsdesk

July 22, 2024 | 1:00 pm

HSIC

Analysts have provided mixed ratings for Henry Schein (NASDAQ:HSIC) over the past three months, with a range of price targets from $72.00 to $92.00. Recent actions include both upgrades and downgrades, reflecting varied sentiment. The company's financials show strong revenue growth, efficient cost management, and a healthy debt-to-equity ratio.

Portfolio Pulse from Benzinga Insights

July 22, 2024 | 1:00 pm

BHVN

CSPI

PTWO

Insiders have made notable purchases in Biohaven Ltd. (BHVN), CSP Inc. (CSPI), and Pono Capital Two, Inc. (PTWO), indicating confidence in these companies' prospects. Biohaven's director bought $1.01M worth of shares, CSP's 10% owner acquired $39,235 worth of shares, and Pono Capital Two's 10% owner purchased $70,278 worth of shares.

Portfolio Pulse from Avi Kapoor

July 22, 2024 | 12:58 pm

BRO

Brown & Brown, Inc. (NYSE:BRO) is set to release its Q2 earnings on July 22, with analysts expecting an EPS of 88 cents and revenue of $1.14 billion. The company recently declared a quarterly dividend of 13 cents per share. To earn $500 monthly from dividends, an investment of approximately $1,066,803 is required.

Portfolio Pulse from Avi Kapoor

July 22, 2024 | 12:56 pm

ON

ON Semiconductor shares are trading higher after the company signed a multi-year power box supply deal with Volkswagen.

Portfolio Pulse from Benzinga Newsdesk

July 22, 2024 | 12:56 pm

TSLA

Tesla Inc (NASDAQ:TSLA) is expected to report Q2 earnings of 60 cents per share and $24.2 billion in revenues on July 23. The stock has mixed technical signals but shows potential for a Golden Cross, which could be a bullish indicator. Analysts have a Neutral rating with a price target of $191.89, but recent ratings suggest a 5.19% upside.

Portfolio Pulse from Surbhi Jain

July 22, 2024 | 12:56 pm